Table 6 Summary statistics for outpatient visits for patients receiving systemic therapy and/or supportive care
From: The cost of unresectable stage III or stage IV melanoma in Italy
Overall | First-line therapy | Second-line therapy | Third-line therapy | Supportive care | ||
|---|---|---|---|---|---|---|
N | 215 | 147 | 112 | 41 | 24 | |
Patients with any outpatient visits | N | 87 | 44 | 36 | 19 | 15 |
% | 40,5% | 29,9% | 32,1% | 46,3% | 62,5% | |
Total number of outpatient visits per visited patient | Mean | 3,3 | 2,4 | 2,5 | 2,5 | 2,7 |
95%CI | 2,8-3,7 | 2,1-2,8 | 2-3 | 1,8-3,2 | 1,9-3,4 | |
Total number of outpatient visits per visited patient per month (1) | Mean | 0,3 | 0,5 | 0,6 | 0,5 | 3,3 |
95%CI | 0,2-0,4 | 0,3-0,7 | 0,3-0,9 | 0,4-0,7 | 0-7,1 | |
Total outpatient cost per visited patient (€ 2009) | Mean | 70 | 50 | 60 | 50 | 60 |
95% CI | 60-80 | 50-60 | 40-70 | 40-70 | 40-80 | |
Total outpatient cost per visited patient per month (€ 2009) | Mean | 7 | 11 | 13 | 11 | 73 |
95% CI | 4-9 | 7-15 | 7-20 | 9-15 | 0-156 | |
Total outpatient cost per patient (€ 2009) | Mean | 28 | 15 | 19 | 23 | 38 |